About Insmed Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://insmed.com/
Frequently Asked Questions
What is the 52-week range for INSM?
The 52-week high is $212.75 and the 52-week low is $90.39.
What is the P/E ratio for INSM?
The P/E ratio data is currently unavailable.
What is the dividend yield for INSM?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -111.26%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -76.94%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 50.23.
Analyst Recommendation Trends
Wall Street analyst consensus for INSM over the last few months:
Latest INSM News
Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback
LQDA faces a major setback as a patent ruling threatens Yutrepia's PH-ILD indication and creates uncertainty around its commercial outlook.
Barclays Maintains Overweight on Insmed, Lowers Price Target to $207
Barclays analyst Eliana Merle maintains Insmed (NASDAQ:INSM) with a Overweight and lowers the price target from $237 to $207.
$1000 Invested In Insmed 15 Years Ago Would Be Worth This Much Today
Insmed (NASDAQ:INSM) has outperformed the market over the past 15 years by 11.06% on an annualized basis producing an average annual return of 24.7%. Currently, Insmed has a market capitalization of $25.54 billion.
Insmed (INSM) Gets Faster FDA Review. Can Its Lung Drug Reach More Patients?
Insmed Incorporated (NASDAQ:INSM) announced on September 21 that the FDA accepted its supplemental application for ARIKAYCE and granted priority review, setting January 28, 2027, as the target decision date. The application seeks full approval and broader use alongside other antibiotics for Mycobacterium avium complex, or MAC, lung disease, a serious bacterial infection. ARIKAYCE currently has […]
What BioPharma Credit (BPCP) Said on Its H1 Earnings Call
BioPharma Credit (LON:BPCP) reported a higher share price and continued portfolio diversification in its half-year investor presentation, while manager Pharmakon said it is managing cash to support new lending opportunities and potential future repayments. Pedro Gonzalez de Cosio, chief executive o
Goldman Sachs Reinstates Buy on Insmed, Announces $188 Price Target
Goldman Sachs analyst Andrea Newkirk reinstates Insmed (NASDAQ:INSM) with a Buy and announces $188 price target.
Can LQDA's Yutrepia Outpace Intensifying PAH Competition?
Liquidia's Yutrepia posts rapid sales growth, but intensifying competition from established therapies and emerging drugs could test its momentum.
FDA Accepts Insmed's Filing Seeking Label Expansion for Arikayce
INSM's Arikayce label expansion gets FDA priority review, potentially broadening its use in newly diagnosed MAC lung disease.
Insmed: Expensive Stock, But Discount To Recent Highs Makes Bull Case
Insmed Incorporated is rated a Buy, driven by Brinsupriâs blockbuster launch and strong TPIP Phase 2b data. Read more on INSM stock here.
Did FDA Priority Review of ARIKAYCE ENCORE Data Just Shift Insmed's (INSM) Investment Narrative?
Insmed has reported that the U.S. FDA previously accepted its supplemental New Drug Application for ARIKAYCE for MAC lung disease under Priority Review, with a target action date of January 28, 2027, based on positive Phase 3b ENCORE data fulfilling a key post-marketing requirement. The ENCORE trial results could allow ARIKAYCE to be used earlier in the MAC disease course and support label expansion discussions in Japan, potentially broadening its treatment reach while maintaining a safety...
FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of MAC Lung Disease With PDUFA Target Action Date Set for January 28, 2027
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's Supplemental New Drug Application (sNDA) for review of ARIKAYCE® (amikacin liposome inhalation suspension) for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacte
The FDA Accepts Insmed's Supplemental New Drug Application For Review Of Arikayce (Amikacin Liposome Inhalation Suspension) For Mycobacterium Avium Complex Lung Disease As Part Of Combination Antibacterial Drug Regimen, With Target Action Date Of January 28, 2027
Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that
The Fund Exited Insmed (INSM) After the Investment Thesis Played Out
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” second-quarter 2026 investor letter. The letter can be downloaded here. During the quarter, the Fund (Investor Shares) returned 17.49% (net of fees), outperforming the Russell 1000 Growth Index’s 16.74%. Holdings in Information Technology and Consumer Discretionary sectors boosted relative returns, while Communication Services […]
Insmed Expands Community Impact During Fifth Annual Global Day of Good
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today holds its fifth annual Global Day of Good, a company-wide day of service during which employees volunteer simultaneously in their respective communities around the world.
Roth Capital Reiterates Buy on Insmed, Lowers Price Target to $198
Roth Capital analyst Adam Walsh reiterates Insmed (NASDAQ:INSM) with a Buy and lowers the price target from $212 to $198.
Insmed (NASDAQ:INSM) Sets Up for Breakout With Strong Technicals
INSMED shows a strong technical breakout setup with a 7 health rating, 9 setup quality, and key resistance at 131.11.
HQL: The Rally That Makes Growth Harder (Rating Downgrade)
HQL downgraded to Hold after big rally; 12.5% yield, NAV discount and payout risks weigh on upside.
Insmed Incorporated (INSM) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Insmed Incorporated (INSM) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 2:35 PM EDTCompany ParticipantsWilliam Lewis -...
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
Liquidia's Yutrepia is gaining traction, but patent litigation, competition, rising costs and heavy product dependence cloud LQDA's outlook.
Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio?
Liquidia's Yutrepia wins FDA Fast Track status for SSc-related Raynaud's, opening a potential new growth avenue for the lead drug.
Exiting Insmed (INSM) Following Disappointing Key Drug Uptake
American Century Investments, an investment management company, released its second-quarter 2026 investor letter for the “American Century Investments Focused Dynamic Growth Fund”. The letter can be downloaded here. U.S. stocks advanced sharply with double-digit quarterly gains largely due to robust earnings, resilient economic data, and momentum in AI-related stocks. However, there was a slight pullback […]
Insmed Incorporated (INSM) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
Insmed Incorporated (INSM) 12th Annual Cantor Fitzgerald Global Healthcare Conference September 9, 2026 8:00 AM EDTCompany ParticipantsSara Bonstein - Chief...
Insmed: A Strong Launch And A Much Bigger Peak Sales Opportunity
Insmed is rated Strong Buy with a $175 target, offering ~39% upside from current levels.
Here's How Much $100 Invested In Insmed 5 Years Ago Would Be Worth Today
Insmed (NASDAQ:INSM) has outperformed the market over the past 5 years by 24.42% on an annualized basis producing an average annual return of 35.99%. Currently, Insmed has a market capitalization of $27.58 billion.
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement awards to 128 new employees. The awards were granted under the Insmed Incorporated 2025 Inducement Plan, which is intended to meet the requirements of a plan providing for inducement grants under Nasdaq Listing Rule 5635(c)(4). The awards were approved by In
Insmed to Present Data Across Its Respiratory Portfolio, Including New Late-Breaking ARIKAYCE® (amikacin liposome inhalation suspension) Results From Phase 3b ENCORE Study at the European Respiratory Society Congress 2026
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that five abstracts highlighting data from its respiratory portfolio have been accepted for presentation at the European Respiratory Society (ERS) Congress 2026 taking place Sept. 5–9, 2026, in Barcelona.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-09 | Brennan David R | -25,000 | $124 | $3,100,000 |
| 2026-08-17 | SHAROKY MELVIN MD | -5,000 | $127.53 | $637,650 |
| 2026-08-10 | Adsett Roger | -80,970 | - | - |
| 2026-08-10 | Adsett Roger | -76,600 | - | - |
| 2026-08-10 | Adsett Roger | -82,280 | - | - |
| 2026-08-10 | Adsett Roger | -239,850 | $133.27 | $31,964,810 |
| 2026-08-10 | Adsett Roger | +80,970 | $30.46 | $2,466,346 |
| 2026-08-10 | Adsett Roger | +76,600 | $17.16 | $1,314,456 |
| 2026-08-10 | Adsett Roger | +82,280 | $13.67 | $1,124,768 |
| 2026-08-06 | Flammer Martina M.D. | -8,895 | - | - |
| 2026-08-06 | Flammer Martina M.D. | -18,278 | - | - |
| 2026-08-06 | Flammer Martina M.D. | -18,278 | $129.4 | $2,365,173 |
| 2026-08-06 | Flammer Martina M.D. | -8,895 | $127 | $1,129,665 |
| 2026-08-06 | Flammer Martina M.D. | +8,895 | $25.83 | $229,758 |
| 2026-08-06 | Flammer Martina M.D. | +18,278 | $18.95 | $346,368 |
| 2026-07-23 | Lewis William | -4,440 | - | - |
| 2026-07-23 | Lewis William | -6,260 | - | - |
| 2026-07-23 | Lewis William | -5,872 | $106.43 | $624,957 |
| 2026-07-23 | Lewis William | -4,828 | $105.62 | $509,933 |
| 2026-07-23 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-07-23 | Lewis William | +6,260 | $30.46 | $190,680 |
| 2026-07-09 | Lewis William | -4,440 | - | - |
| 2026-07-09 | Lewis William | -6,259 | - | - |
| 2026-07-09 | Lewis William | -3,359 | $118.52 | $398,109 |
| 2026-07-09 | Lewis William | -2,335 | $117.62 | $274,643 |
| 2026-07-09 | Lewis William | -5,005 | $116.55 | $583,333 |
| 2026-07-09 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-07-09 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2026-07-06 | Flammer Martina M.D. | -4,357 | - | - |
| 2026-07-06 | Flammer Martina M.D. | -7,945 | - | - |
| 2026-07-06 | Flammer Martina M.D. | -7,448 | $110.6 | $823,749 |
| 2026-07-06 | Flammer Martina M.D. | -4,854 | $109.02 | $529,183 |
| 2026-07-06 | Flammer Martina M.D. | +4,357 | $19.74 | $86,007 |
| 2026-07-06 | Flammer Martina M.D. | +7,945 | $29.13 | $231,438 |
| 2026-06-25 | Lewis William | -8,880 | - | - |
| 2026-06-25 | Lewis William | -12,518 | - | - |
| 2026-06-25 | Lewis William | -1,292 | $106.27 | $137,301 |
| 2026-06-25 | Lewis William | -2,456 | $105.27 | $258,543 |
| 2026-06-25 | Lewis William | -3,723 | $104.28 | $388,234 |
| 2026-06-25 | Lewis William | -1,836 | $103.1 | $189,292 |
| 2026-06-25 | Lewis William | -12,091 | $102.34 | $1,237,393 |
| 2026-06-25 | Lewis William | +8,880 | $17.16 | $152,381 |
| 2026-06-25 | Lewis William | +12,518 | $30.46 | $381,298 |
| 2026-06-23 | Butera Samuele | +12,570 | - | - |
| 2026-06-23 | Butera Samuele | +7,342 | - | - |
| 2026-06-22 | Smith Michael Alexander | -1,806 | $95.82 | $173,051 |
| 2026-06-08 | Lewis William | -6,515 | $94.03 | $612,605 |
| 2026-06-05 | Flammer Martina M.D. | -1,858 | $103.78 | $192,823 |
| 2026-06-03 | Smith Michael Alexander | -2,159 | $102.27 | $220,801 |
| 2026-06-03 | Flammer Martina M.D. | -2,566 | $102.27 | $262,425 |
| 2026-06-03 | Adsett Roger | -2,370 | $102.27 | $242,380 |
| 2026-06-03 | Bonstein Sara | -2,404 | $102.27 | $245,857 |
| 2026-06-03 | Lewis William | -7,605 | $102.27 | $777,763 |
| 2026-05-22 | Smith Michael Alexander | -6,149 | $108.47 | $666,982 |
| 2026-05-18 | Lewis William | -4,440 | - | - |
| 2026-05-18 | Lewis William | -6,259 | - | - |
| 2026-05-18 | Lewis William | -7,975 | $106.97 | $853,086 |
| 2026-05-18 | Lewis William | -11,836 | $106.39 | $1,259,232 |
| 2026-05-18 | Lewis William | -5,753 | $105.32 | $605,906 |
| 2026-05-18 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-05-18 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2026-05-14 | Flammer Martina M.D. | -10,479 | $117.54 | $1,231,702 |
| 2026-05-13 | Smith Michael Alexander | -4,109 | $116.18 | $477,384 |
| 2026-05-13 | Flammer Martina M.D. | -3,384 | $116.18 | $393,153 |
| 2026-05-13 | Flammer Martina M.D. | -4,470 | $112.76 | $504,037 |
| 2026-05-13 | Desjardins Clarissa | +3,305 | - | - |
| 2026-05-13 | ANDERSON ELIZABETH M | +3,305 | - | - |
| 2026-05-13 | LEE LEO | +3,305 | - | - |
| 2026-05-13 | Adsett Roger | -5,837 | $116.18 | $678,143 |
| 2026-05-13 | Brennan David R | +3,305 | - | - |
| 2026-05-13 | Bonstein Sara | -8,272 | $116.18 | $961,041 |
| 2026-05-13 | Lewis William | -13,283 | $116.18 | $1,543,219 |
| 2026-05-13 | SCHAFER CAROL | +3,305 | - | - |
| 2026-05-13 | SHAROKY MELVIN MD | +3,305 | - | - |
| 2026-05-11 | Flammer Martina M.D. | -12,949 | - | - |
| 2026-05-11 | Flammer Martina M.D. | -830 | $101.18 | $83,979 |
| 2026-05-11 | Flammer Martina M.D. | -12,119 | $100.35 | $1,216,142 |
| 2026-05-11 | Flammer Martina M.D. | +12,949 | $17.07 | $221,039 |
| 2026-05-04 | Lewis William | -4,440 | - | - |
| 2026-05-04 | Lewis William | -6,259 | - | - |
| 2026-05-04 | Lewis William | -381 | $139.6 | $53,188 |
| 2026-05-04 | Lewis William | -1,247 | $139.09 | $173,445 |
| 2026-05-04 | Lewis William | -2,721 | $137.86 | $375,117 |
| 2026-05-04 | Lewis William | -5,318 | $137.01 | $728,619 |
| 2026-05-04 | Lewis William | -599 | $135.18 | $80,973 |
| 2026-05-04 | Lewis William | -433 | $134.18 | $58,100 |
| 2026-05-04 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-05-04 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2026-04-16 | Lewis William | -4,440 | - | - |
| 2026-04-16 | Lewis William | -6,259 | - | - |
| 2026-04-16 | Lewis William | -825 | $145.79 | $120,277 |
| 2026-04-16 | Lewis William | -2,255 | $144.66 | $326,208 |
| 2026-04-16 | Lewis William | -5,373 | $143.81 | $772,691 |
| 2026-04-16 | Lewis William | -2,246 | $142.99 | $321,156 |
| 2026-04-16 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-04-16 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2026-04-06 | Lewis William | -4,440 | - | - |
| 2026-04-06 | Lewis William | -6,259 | - | - |
| 2026-04-06 | Lewis William | -1,434 | $164.01 | $235,190 |
| 2026-04-06 | Lewis William | -8,478 | $163.23 | $1,383,864 |
| 2026-04-06 | Lewis William | -787 | $161.73 | $127,282 |
| 2026-04-06 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-04-06 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2026-04-01 | Adsett Roger | -88,060 | - | - |
| 2026-04-01 | Adsett Roger | -62,344 | $164.95 | $10,283,643 |
| 2026-04-01 | Adsett Roger | -19,001 | $164.11 | $3,118,254 |
| 2026-04-01 | Adsett Roger | -6,715 | $163.18 | $1,095,754 |
| 2026-04-01 | Adsett Roger | +88,060 | $14.56 | $1,282,154 |
| 2026-03-30 | Smith Michael Alexander | -13,989 | - | - |
| 2026-03-30 | Smith Michael Alexander | -5,649 | - | - |
| 2026-03-30 | Smith Michael Alexander | -19,638 | $150.98 | $2,964,945 |
| 2026-03-30 | Smith Michael Alexander | +13,989 | $27.89 | $390,153 |
| 2026-03-30 | Smith Michael Alexander | +5,649 | $17.07 | $96,428 |
| 2026-03-19 | Lewis William | -4,440 | - | - |
| 2026-03-19 | Lewis William | -6,259 | - | - |
| 2026-03-19 | Lewis William | -4,533 | $144.11 | $653,251 |
| 2026-03-19 | Lewis William | -4,537 | $143.42 | $650,697 |
| 2026-03-19 | Lewis William | -1,629 | $142.17 | $231,595 |
| 2026-03-19 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-03-19 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2026-03-05 | Lewis William | -4,440 | - | - |
| 2026-03-05 | Lewis William | -6,259 | - | - |
| 2026-03-05 | Lewis William | -2,128 | $147.54 | $313,965 |
| 2026-03-05 | Lewis William | -3,899 | $146.66 | $571,827 |
| 2026-03-05 | Lewis William | -2,589 | $145.27 | $376,104 |
| 2026-03-05 | Lewis William | -2,083 | $144.23 | $300,431 |
| 2026-03-05 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-03-05 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2026-03-03 | SHAROKY MELVIN MD | -100 | - | - |
| 2026-02-25 | SHAROKY MELVIN MD | +243 | - | - |
| 2026-02-25 | SHAROKY MELVIN MD | +243 | - | - |
| 2026-02-25 | SHAROKY MELVIN MD | +243 | - | - |
| 2026-02-25 | SHAROKY MELVIN MD | +243 | - | - |
| 2026-02-25 | SHAROKY MELVIN MD | -1,072 | - | - |
| 2026-02-24 | Smith Michael Alexander | -20,248 | - | - |
| 2026-02-24 | Smith Michael Alexander | -15,771 | $156.53 | $2,468,635 |
| 2026-02-24 | Smith Michael Alexander | -4,151 | $155.06 | $643,654 |
| 2026-02-24 | Smith Michael Alexander | -4,852 | $153.93 | $746,868 |
| 2026-02-24 | Smith Michael Alexander | +20,248 | $17.07 | $345,633 |
| 2026-02-23 | Brennan David R | -6,000 | - | - |
| 2026-02-19 | Lewis William | -4,440 | - | - |
| 2026-02-19 | Lewis William | -6,259 | - | - |
| 2026-02-19 | Lewis William | -1,030 | $153.38 | $157,981 |
| 2026-02-19 | Lewis William | -2,377 | $151.92 | $361,114 |
| 2026-02-19 | Lewis William | -3,413 | $151.12 | $515,773 |
| 2026-02-19 | Lewis William | -1,891 | $150.1 | $283,839 |
| 2026-02-19 | Lewis William | -1,988 | $149.17 | $296,550 |
| 2026-02-19 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-02-19 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2026-02-09 | Lewis William | -6,259 | - | - |
| 2026-02-09 | Lewis William | -4,440 | - | - |
| 2026-02-09 | Lewis William | -1,287 | $148.83 | $191,544 |
| 2026-02-09 | Lewis William | -7,221 | $148.02 | $1,068,852 |
| 2026-02-09 | Lewis William | -4,888 | $147.17 | $719,367 |
| 2026-02-09 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2026-02-09 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-02-09 | MCGIRR DAVID W J | +53,400 | - | - |
| 2026-02-09 | MCGIRR DAVID W J | -53,400 | - | - |
| 2026-02-05 | Flammer Martina M.D. | -869 | $152.44 | $132,470 |
| 2026-02-03 | Smith Michael Alexander | -640 | $156.27 | $100,013 |
| 2026-02-03 | Flammer Martina M.D. | -795 | $155.77 | $123,837 |
| 2026-02-03 | Adsett Roger | -791 | $156.17 | $123,530 |
| 2026-02-03 | Bonstein Sara | -748 | $156.34 | $116,942 |
| 2026-02-03 | Lewis William | -3,009 | $156.34 | $470,427 |
| 2026-02-02 | Flammer Martina M.D. | -7,982 | - | - |
| 2026-02-02 | Flammer Martina M.D. | -100 | $156.86 | $15,686 |
| 2026-02-02 | Flammer Martina M.D. | -3,042 | $155.46 | $472,909 |
| 2026-02-02 | Flammer Martina M.D. | -3,349 | $154.56 | $517,621 |
| 2026-02-02 | Flammer Martina M.D. | -928 | $153.16 | $142,132 |
| 2026-02-02 | Flammer Martina M.D. | -563 | $152.06 | $85,610 |
| 2026-02-02 | Flammer Martina M.D. | +7,982 | $65.72 | $524,577 |
| 2026-01-20 | Lewis William | -4,440 | - | - |
| 2026-01-20 | Lewis William | -6,259 | - | - |
| 2026-01-20 | Lewis William | -254 | $160.7 | $40,818 |
| 2026-01-20 | Lewis William | -2,229 | $159.85 | $356,306 |
| 2026-01-20 | Lewis William | -5,967 | $158.99 | $948,693 |
| 2026-01-20 | Lewis William | -1,243 | $158.37 | $196,854 |
| 2026-01-20 | Lewis William | -1,006 | $156.8 | $157,741 |
| 2026-01-20 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-01-20 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2026-01-12 | Lewis William | -4,440 | - | - |
| 2026-01-12 | Lewis William | -6,259 | - | - |
| 2026-01-12 | Lewis William | -315 | $174.86 | $55,081 |
| 2026-01-12 | Lewis William | -297 | $172.36 | $51,191 |
| 2026-01-12 | Lewis William | -297 | $171.31 | $50,879 |
| 2026-01-12 | Lewis William | -160 | $170.24 | $27,238 |
| 2026-01-12 | Lewis William | -6,996 | $169.57 | $1,186,312 |
| 2026-01-12 | Lewis William | -7,176 | $168.63 | $1,210,089 |
| 2026-01-12 | Lewis William | -3,974 | $167.73 | $666,559 |
| 2026-01-12 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2026-01-12 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2026-01-09 | Flammer Martina M.D. | -1,887 | $186.19 | $351,341 |
| 2026-01-08 | Smith Michael Alexander | -1,053 | $174.17 | $183,401 |
| 2026-01-08 | Flammer Martina M.D. | -3,251 | $174.17 | $566,227 |
| 2026-01-08 | Flammer Martina M.D. | -1,660 | $173.87 | $288,624 |
| 2026-01-08 | Adsett Roger | -2,059 | $174.17 | $358,616 |
| 2026-01-08 | Bonstein Sara | -1,447 | $174.17 | $252,024 |
| 2026-01-08 | Lewis William | -3,223 | $174.17 | $561,350 |
| 2026-01-07 | Smith Michael Alexander | -709 | $175.07 | $124,125 |
| 2026-01-07 | Flammer Martina M.D. | -1,434 | $175.84 | $252,155 |
| 2026-01-07 | Adsett Roger | -802 | $175.07 | $140,406 |
| 2026-01-07 | Bonstein Sara | -1,678 | $175.07 | $293,767 |
| 2026-01-07 | Lewis William | -2,357 | $175.07 | $412,640 |
| 2026-01-06 | Smith Michael Alexander | -1,396 | $173.33 | $241,969 |
| 2026-01-06 | Flammer Martina M.D. | -8,570 | - | - |
| 2026-01-06 | Flammer Martina M.D. | -1,615 | $173.33 | $279,928 |
| 2026-01-06 | Flammer Martina M.D. | -957 | $175.01 | $167,485 |
| 2026-01-06 | Flammer Martina M.D. | -2,830 | $174.21 | $493,014 |
| 2026-01-06 | Flammer Martina M.D. | -4,783 | $173.47 | $829,707 |
| 2026-01-06 | Flammer Martina M.D. | +8,570 | $26.43 | $226,505 |
| 2026-01-06 | Adsett Roger | -1,429 | $173.33 | $247,689 |
| 2026-01-06 | Bonstein Sara | -1,517 | $173.33 | $262,942 |
| 2026-01-06 | Lewis William | -4,096 | $173.33 | $709,960 |
| 2026-01-05 | Flammer Martina M.D. | -7,945 | - | - |
| 2026-01-05 | Flammer Martina M.D. | -4,358 | - | - |
| 2026-01-05 | Flammer Martina M.D. | -702 | $175.73 | $123,362 |
| 2026-01-05 | Flammer Martina M.D. | -655 | $174.28 | $114,153 |
| 2026-01-05 | Flammer Martina M.D. | -1,820 | $173.45 | $315,679 |
| 2026-01-05 | Flammer Martina M.D. | -286 | $171.92 | $49,169 |
| 2026-01-05 | Flammer Martina M.D. | -2,836 | $171.19 | $485,495 |
| 2026-01-05 | Flammer Martina M.D. | -3,205 | $170.61 | $546,805 |
| 2026-01-05 | Flammer Martina M.D. | -2,799 | $169.29 | $473,843 |
| 2026-01-05 | Flammer Martina M.D. | +7,945 | $29.13 | $231,438 |
| 2026-01-05 | Flammer Martina M.D. | +4,358 | $19.74 | $86,027 |
| 2026-01-02 | Smith Michael Alexander | +27,600 | - | - |
| 2026-01-02 | Smith Michael Alexander | +5,293 | - | - |
| 2026-01-02 | Flammer Martina M.D. | +31,280 | - | - |
| 2026-01-02 | Flammer Martina M.D. | +5,645 | - | - |
| 2026-01-02 | Flammer Martina M.D. | +5,998 | - | - |
| 2026-01-02 | Adsett Roger | +31,280 | - | - |
| 2026-01-02 | Adsett Roger | +5,998 | - | - |
| 2026-01-02 | Bonstein Sara | +31,280 | - | - |
| 2026-01-02 | Bonstein Sara | +5,645 | - | - |
| 2026-01-02 | Bonstein Sara | +5,998 | - | - |
| 2026-01-02 | Lewis William | +110,400 | - | - |
| 2026-01-02 | Lewis William | +21,172 | - | - |
| 2026-01-02 | Schaeffer Orlov S Nicole | -87,290 | - | - |
| 2026-01-02 | Schaeffer Orlov S Nicole | +27,600 | - | - |
| 2026-01-02 | Schaeffer Orlov S Nicole | -200 | $177.78 | $35,556 |
| 2026-01-02 | Schaeffer Orlov S Nicole | -9,125 | $177.17 | $1,616,676 |
| 2026-01-02 | Schaeffer Orlov S Nicole | -12,832 | $176.08 | $2,259,459 |
| 2026-01-02 | Schaeffer Orlov S Nicole | -34,103 | $175.17 | $5,973,823 |
| 2026-01-02 | Schaeffer Orlov S Nicole | -31,030 | $174.28 | $5,407,908 |
| 2026-01-02 | Schaeffer Orlov S Nicole | +87,290 | $13.91 | $1,214,204 |
| 2026-01-02 | Schaeffer Orlov S Nicole | +5,293 | - | - |
| 2025-12-18 | Lewis William | -6,259 | - | - |
| 2025-12-18 | Lewis William | -4,440 | - | - |
| 2025-12-18 | Lewis William | -51 | $171.2 | $8,731 |
| 2025-12-18 | Lewis William | -362 | $170.26 | $61,634 |
| 2025-12-18 | Lewis William | -1,938 | $169.58 | $328,646 |
| 2025-12-18 | Lewis William | -2,175 | $168.54 | $366,575 |
| 2025-12-18 | Lewis William | -1,431 | $167.29 | $239,392 |
| 2025-12-18 | Lewis William | -1,783 | $166.6 | $297,048 |
| 2025-12-18 | Lewis William | -697 | $165.21 | $115,151 |
| 2025-12-18 | Lewis William | -447 | $164.24 | $73,415 |
| 2025-12-18 | Lewis William | -1,465 | $163.19 | $239,073 |
| 2025-12-18 | Lewis William | -350 | $162.26 | $56,791 |
| 2025-12-18 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2025-12-18 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2025-12-05 | SHAROKY MELVIN MD | -20,000 | $205.01 | $4,100,200 |
| 2025-12-04 | Lewis William | -4,440 | - | - |
| 2025-12-04 | Lewis William | -6,259 | - | - |
| 2025-12-04 | Lewis William | -1,040 | $207.42 | $215,717 |
| 2025-12-04 | Lewis William | -2,921 | $206.49 | $603,157 |
| 2025-12-04 | Lewis William | -2,222 | $205.66 | $456,977 |
| 2025-12-04 | Lewis William | -4,516 | $204.62 | $924,064 |
| 2025-12-04 | Lewis William | +4,440 | $17.16 | $76,190 |
| 2025-12-04 | Lewis William | +6,259 | $30.46 | $190,649 |
| 2025-12-01 | Flammer Martina M.D. | -8,895 | - | - |
| 2025-12-01 | Flammer Martina M.D. | -1,559 | $207.73 | $323,851 |
| 2025-12-01 | Flammer Martina M.D. | -5,886 | $207.03 | $1,218,579 |
| 2025-12-01 | Flammer Martina M.D. | -1,450 | $205.98 | $298,671 |
| 2025-12-01 | Flammer Martina M.D. | +8,895 | $25.83 | $229,758 |
| 2025-11-24 | ANDERSON ELIZABETH M | -5,000 | $204.58 | $1,022,900 |
| 2025-11-17 | LEE LEO | -15,174 | $197.4 | $2,995,348 |
| 2025-11-17 | LEE LEO | -24,076 | $196.61 | $4,733,582 |
| 2025-11-17 | LEE LEO | -14,944 | $195.39 | $2,919,908 |
| 2025-11-17 | LEE LEO | -17,594 | $194.49 | $3,421,857 |
| 2025-11-17 | LEE LEO | -3,212 | $193.51 | $621,554 |
| 2025-11-14 | ANDERSON ELIZABETH M | -10,000 | $195.87 | $1,958,700 |
| 2025-11-12 | Schaeffer Orlov S Nicole | -30,000 | - | - |
| 2025-11-12 | Schaeffer Orlov S Nicole | -164 | $195.88 | $32,124 |
| 2025-11-12 | Schaeffer Orlov S Nicole | -19,183 | $194.44 | $3,729,943 |
| 2025-11-12 | Schaeffer Orlov S Nicole | -6,575 | $193.64 | $1,273,183 |
| 2025-11-12 | Schaeffer Orlov S Nicole | -4,078 | $192.45 | $784,811 |
| 2025-11-12 | Schaeffer Orlov S Nicole | +30,000 | $26.46 | $793,800 |
| 2025-11-11 | Flammer Martina M.D. | -18,277 | - | - |
| 2025-11-11 | Flammer Martina M.D. | -12,949 | - | - |
| 2025-11-11 | Flammer Martina M.D. | -2,913 | $191.04 | $556,500 |
| 2025-11-11 | Flammer Martina M.D. | -10,622 | $190.33 | $2,021,685 |
| 2025-11-11 | Flammer Martina M.D. | -12,224 | $189.36 | $2,314,737 |
| 2025-11-11 | Flammer Martina M.D. | -5,467 | $188.38 | $1,029,873 |
| 2025-11-11 | Flammer Martina M.D. | +18,277 | $18.95 | $346,349 |
| 2025-11-11 | Flammer Martina M.D. | +12,949 | $17.07 | $221,039 |
| 2025-11-06 | Brennan David R | +60,000 | - | - |
| 2025-11-06 | Brennan David R | -60,000 | - | - |
| 2025-11-03 | Smith Michael Alexander | -27,130 | - | - |
| 2025-11-03 | Smith Michael Alexander | -1,400 | $187.97 | $263,158 |
| 2025-11-03 | Smith Michael Alexander | -1,572 | $187.15 | $294,200 |
| 2025-11-03 | Smith Michael Alexander | -3,636 | $185.93 | $676,041 |
| 2025-11-03 | Smith Michael Alexander | -3,243 | $184.91 | $599,663 |
| 2025-11-03 | Smith Michael Alexander | -4,032 | $183.92 | $741,565 |
| 2025-11-03 | Smith Michael Alexander | -4,286 | $182.6 | $782,624 |
| 2025-11-03 | Smith Michael Alexander | -7,619 | $181.88 | $1,385,744 |
| 2025-11-03 | Smith Michael Alexander | -1,342 | $181.01 | $242,915 |
| 2025-11-03 | Smith Michael Alexander | +27,130 | $23.75 | $644,338 |